Literature DB >> 23562944

Which follicles make the most anti-Mullerian hormone in humans? Evidence for an abrupt decline in AMH production at the time of follicle selection.

J V Jeppesen1, R A Anderson, T W Kelsey, S L Christiansen, S G Kristensen, K Jayaprakasan, N Raine-Fenning, B K Campbell, C Yding Andersen.   

Abstract

Anti-Müllerian hormone (AMH) is exclusively produced by granulosa cells (GC) of the developing pre-antral and antral follicles, and AMH is increasingly used to assess ovarian function. It is unclear which size follicles make the most AMH (total content) and are the main contributors to circulating AMH concentrations. To determine AMH gene expression in GC (q-RT-PCR) and follicular AMH production (Elisa and RIA) in relation to follicular development, 87 follicles (3-13 mm diameter) including both GC and the corresponding follicular fluid (FF) were collected in connection with fertility preservation of human ovaries. Further, follicle number and diameter, graded in 1 mm increments, were determined by 3D ultrasound in 113 women in their natural menstrual cycle to determine follicle number and diameter in relation to circulating AMH levels. This study demonstrates for the first time a positive association between AMH gene expression in human and both total follicular fluid AMH (P < 0.02) and follicular fluid AMH concentration (P < 0.01). AMH gene expression and total AMH protein increased until a follicular diameter of 8 mm, after which a sharp decline occurred. In vivo modelling confirmed that 5-8 mm follicles make the greatest contribution to serum AMH, estimated for the first time in human to be 60% of the circulating concentration. Significant positive associations between gene expression of AMH and FSHR, AR and AMHR2 expression (P < 0.00001 for all three) and significant negative association between follicular fluid AMH concentration and CYP19a1 expression were found (P < 0.0001). Both AMH gene expression (P < 0.02) and follicular fluid concentration of AMH (P < 0.00001) correlated negatively with estradiol concentration.

Entities:  

Keywords:  AMH; follicular fluid; granulosa cells; human small antral follicles; modelling

Mesh:

Substances:

Year:  2013        PMID: 23562944     DOI: 10.1093/molehr/gat024

Source DB:  PubMed          Journal:  Mol Hum Reprod        ISSN: 1360-9947            Impact factor:   4.025


  72 in total

1.  The anti-Müllerian hormone (AMH) acts as a gatekeeper of ovarian steroidogenesis inhibiting the granulosa cell response to both FSH and LH.

Authors:  Sandro Sacchi; Giovanni D'Ippolito; Paola Sena; Tiziana Marsella; Daniela Tagliasacchi; Elena Maggi; Cindy Argento; Alessandra Tirelli; Simone Giulini; Antonio La Marca
Journal:  J Assist Reprod Genet       Date:  2015-12-02       Impact factor: 3.412

2.  Anti-Müllerian hormone promotes pre-antral follicle growth, but inhibits antral follicle maturation and dominant follicle selection in primates.

Authors:  J Xu; C V Bishop; M S Lawson; B S Park; F Xu
Journal:  Hum Reprod       Date:  2016-05-09       Impact factor: 6.918

3.  Serum anti-Mullerian hormone predicts ovarian response in (Macaca fascicularis) monkeys.

Authors:  Hui Long; Yanhong Nie; Li Wang; Yong Lu; Yan Wang; Yijun Cai; Zhen Liu; Miaomiao Jia; Qifeng Lyu; Yanping Kuang; Qiang Sun
Journal:  Endocr Connect       Date:  2018-08-09       Impact factor: 3.335

4.  AMH is Higher Across the Menstrual Cycle in Early Postmenarchal Girls than in Ovulatory Women.

Authors:  Madison T Ortega; Lauren Carlson; John A McGrath; Tairmae Kangarloo; Judith Mary Adams; Patrick M Sluss; Geralyn Lambert-Messerlian; Natalie D Shaw
Journal:  J Clin Endocrinol Metab       Date:  2020-04-01       Impact factor: 5.958

5.  Regulation of AMH by oocyte-specific growth factors in human primary cumulus cells.

Authors:  Scott Convissar; Marah Armouti; Michelle A Fierro; Nicola J Winston; Humberto Scoccia; A Musa Zamah; Carlos Stocco
Journal:  Reproduction       Date:  2017-09-05       Impact factor: 3.906

6.  Distinctive Reproductive Phenotypes in Peripubertal Girls at Risk for Polycystic Ovary Syndrome.

Authors:  Laura C Torchen; Richard S Legro; Andrea Dunaif
Journal:  J Clin Endocrinol Metab       Date:  2019-08-01       Impact factor: 5.958

Review 7.  Genetics of androgen metabolism in women with infertility and hypoandrogenism.

Authors:  Aya Shohat-Tal; Aritro Sen; David H Barad; Vitaly Kushnir; Norbert Gleicher
Journal:  Nat Rev Endocrinol       Date:  2015-05-05       Impact factor: 43.330

8.  Clinical pregnancy in a woman with idiopathic hypogonadotropic hypogonadism and low AMH: utility of ovarian reserve markers in IHH.

Authors:  Crystal Chan; Kimberly Liu
Journal:  J Assist Reprod Genet       Date:  2014-08-12       Impact factor: 3.412

9.  Effect of growth hormone receptor gene disruption and PMA treatment on the expression of genes involved in primordial follicle activation in mice ovaries.

Authors:  Augusto Schneider; Xu Zhi; Andrzej Bartke; John J Kopchick; Michal M Masternak
Journal:  Age (Dordr)       Date:  2014-08-07

10.  Serum anti-Müllerian hormone levels in women are unstable in the postpartum period but return to normal within 5 months: a longitudinal study.

Authors:  Michael W Pankhurst; Annelien C de Kat; Shirley Jones; Frank J M Broekmans; Benjamin J Wheeler
Journal:  Endocrine       Date:  2020-09-11       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.